OS THERAPIES

os-therapies-logo

OS Therapies (OST) is a clinical-stage therapeutics company focused on the identification, development, and commercialization of treatments for Osteosarcoma (OS). OS Therapies was launched to meet the significant unmet need for new treatments in cancers of the bone in kids and adults. Osteosarcoma is an extremely challenging and often aggressive cancer that has particular treatment challenges due to location, changing genotypes, and high recurrence rates. At OST, they are trying to answer the calls for new treatments, considering there have been no new treatments for OS in over 30 years.

#People #Financial #Website #More

OS THERAPIES

Industry:
Health Care Pharmaceutical Therapeutics

Founded:
2017-01-01

Address:
Fairfax, Virginia, United States

Country:
United States

Website Url:
http://www.ostherapies.com

Status:
Active

Total Funding:
7 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Content Delivery Network Typekit Squarespace Twitter CDN


Current Employees Featured

robert-g-petit_image

Robert G. Petit
Robert G. Petit Chief Medical & Scientific Officer for OS Therapies @ OS Therapies
Chief Medical & Scientific Officer for OS Therapies
2019-01-01

paul-romness_image

Paul Romness
Paul Romness CEO & Founder @ OS Therapies
CEO & Founder
2017-10-01

Founder


paul-romness_image

Paul Romness

Investors List

noble-capital-markets_image

Noble Capital Markets

Noble Capital Markets investment in Series A - OS Therapies

tichenor-ventures_image

Tichenor Ventures

Tichenor Ventures investment in Series A - OS Therapies

Official Site Inspections

http://www.ostherapies.com Semrush global rank: 4.83 M Semrush visits lastest month: 1.86 K

  • Host name: 124.152.227.35.bc.googleusercontent.com
  • IP address: 35.227.152.124
  • Location: Mountain View United States
  • Latitude: 37.4043
  • Longitude: -122.0748
  • Metro Code: 807
  • Timezone: America/Los_Angeles
  • Postal: 94043

Loading ...

More informations about "OS Therapies" on Search Engine